Tumour-stroma interaction: Cancer-associated fibroblasts as novel targets in anti-cancer therapy?

Lung Cancer

Volumn 45, Issue SUPPL. 2, 2004, Pages

  Micke, Patrick ^a   Östman, Arne ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

Cancer associated fibroblasts; Lung cancer; Myofibroblasts; PDGF; Prostate cancer; Reactive stroma; Stroma; Targeted therapy; TGF 1 Laser microdissection; Tumour stroma interaction

Indexed keywords

IMATINIB; LY 364947; MONOCLONAL ANTIBODY; NPC 30345; PLATELET DERIVED GROWTH FACTOR; RECEPTOR BLOCKING AGENT; SBI 14352; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER MODEL; CANCER THERAPY; CARCINOMA; CELL CONTACT; CELL DIFFERENTIATION; CELL FUNCTION; CELLULAR DISTRIBUTION; CLINICAL TRIAL; COCULTURE; COLON CANCER; COLORECTAL CANCER; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; DNA MICROARRAY; DRUG MECHANISM; DRUG TARGETING; EPITHELIUM CELL; EXPERIMENT; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; IN VIVO STUDY; INFLAMMATION; LUNG CANCER; LUNG CARCINOGENESIS; METASTASIS; MICROENVIRONMENT; MYOFIBROBLAST; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA; STROMA CELL; TRANSGENIC ANIMAL; TUMOR; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; LUNG NEOPLASMS; MUSCLE CELLS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PLATELET-DERIVED GROWTH FACTOR; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 8444250723     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.07.977     Document Type: Conference Paper

References (141)

1. DeWever 0., and Mareel M. Role of tissue stroma in cancer cell invasion J Pathol 200 2003 429 447
2. Willis R. Pathology of Tumors 4th edition 1967 Butterworth and Company London
3. Powell D.W., Mifflin R.C., and Valentich J.D. Myofibroblasts. I. Paracrine cells important in health and disease Am J Physiol 277 1999 C1 C9
4. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545
5. Coussens L.M., and Werb Z. Inflammation and cancer Nature 420 2002 860 867
6. Dvorak H.E. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing N Engl J Med 315 1986 1650 1659
7. Gabbiani G., Ryan G.B., and Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction Experientia 27 1971 549 550
8. DeWever 0., and Mareel M. Role of myofibroblasts at the invasion front Biol Chem 383 2002 55 67
9. Ronnov-Jessen L., Petersen O.W., and Koteliansky V.E. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells J Clin Invest 95 1995 859 873
10. Tsukada T., Tippens D., and Gordon D. HHF35, a muscleactin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization Am J Pathol 126 1987 51 60
11. Arora P.D., and McCulloch C.A. The deletion of transforming growth factor-beta-induced myofibroblasts depends on growth conditions and actin organization Am J Pathol 155 1999 2087 2099
12. Ronnov-Jessen L., Petersen O.W., and Bissell M.J. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction Physiol Rev 76 1996 69 125
13. Grupp C., Lottermoser J., and Cohen D.I. Transformation of rat inner medullary fibroblasts to myofibroblasts in vitro Kidney Int 52 1997 1279 1290
14. Serini G., and Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation Exp Cell Res 250 1999 273 283
15. Schürch W. The myofibroblast in neoplasia Curr Top Pathol 93 1999 135 148
16. Elenbaas B., and Weinberg R.A. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation Exp Cell Res 264 2001 169 184
17. Nakayama H., Enzan H., and Miyazaki E. The role of myofibroblasts at the tumor border of invasive colorectal adenocarcinomas Jpn J Clin Oncol 28 1998 615 620
18. Tuxhorn J.A., Ayala G.E., and Smith M.J. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling Clin Cancer Res 8 2002 2912 2923
19. Orimo A., Tomioka Y., and Shimizu Y. Cancer-associated myofibroblasts poss; various factors to promote endometrial tumor progression Clin Cancer Res 7 2001 3097 3105
20. Ronnov-Jessen L., van Deurs B., and Celis J.E. Smooth muscle differentiation in cultured human breast gland stromal cells Lab Invest 63 1990 532 543
21. Ronnov-Jessen L., Celis J.E., and van Deurs B. A fibroblastassociated antigen: characterization in fibroblasts and immunoreactivity in smooth muscle differentiated stromal cells J Histochem Cytochem 40 1992 475 486
22. Skalli O., Pelte M.F., and Peclet M.C. Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes J Histochem Cytochem 37 1989 315 321
23. Tsukada T., McNutt M.A., and Ross R. HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues Am J Pathol 127 1987 389 402
24. Hast J., Schiffer I.B., and Neugebauer B. Angiogenesis and fibroblast proliferation precede formation of recurrent tumors after radiation therapy in nude mice Anticancer Res 22 2002 677 688
25. Schlingemann R.O., Rietveld F.J., and Kwaspen F. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue Am J Pathol 138 1991 1335 1347
26. Petersen O.W., Nielsen H.L., and Gudjonsson T. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma Am J Pathol 162 2003 391 402
27. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues Science 276 1997 71 74
28. Chauhan H., Abraham A., and Phillips J.R. There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions J Clin Pathol 56 2003 271 276
29. Tlsty T.D. Stromal cells can contribute oncogenic signals Semin Cancer Biol 11 2001 97 104
30. Ellis M.J., Singer C., and Hornby A. Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer Breast Cancer Res Treat 31 1994 249 261
31. Hofer S.O., Molema G., and Hermens R.A. The effect of surgical wounding on tumour development Eur J Surg Oncol 25 1999 231 243
32. Park C.C., Bissell M.J., and Barcellos-Hoff M.H. The influence of the microenvironment on the malignant phenotype Mol Med Today 6 2000 324 329
33. Dumont N., and Arteaga C.L. Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta Breast Cancer Res 2 2000 125 132
34. Walker R.A., and Dearing S.J. Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast Eur J Cancer 28 1992 641 644
35. Annes J.P., Rifkin D.B., and Munger J.S. Making sense of latent TGFbeta activation J Cell Sci 116 2003 217 224
36. Moustakas A., Souchelnytskyi S., and Heldin C.H. Smad regulation in TGF-beta signal transduction J Cell Sci 114 2001 4359 4369
37. Piek E., Heldin C.H., and Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling FASEB J 13 1999 2105 2124
38. Moses H.L., Yang E.Y., and Pietenpol J.A. TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights Cell 63 1990 245 247
39. Pierce D.F. Jr, Johnson M.D., and Matsui Y. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1 Genes Dev 7 1993 2308 2317
40. Talts J.F., Weller A., and Timpl R. Regulation of mesenchymal extracellular matrix protein synthesis by transforming growth factor-beta and glucocorticoids in tumor stroma J Cell Sci 108 1995 2153 2162
41. Overall C.M., Wrana J.L., and Sodek J. Transcriptional and posttranscriptional regulation of 72-kDa gelatinase/type IV coLLagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with coLLagenase and tissue inhibitor of matrix metaLLoproteinase gene expression J Biol Chem 266 1991 14064 14071
42. Janji B., Melchior C., and Gouon V. Autocrine TGF-betaregulated expression of adhesion receptors and integrinLinked kinase in HT-144 melanoma cells correlates with their metastatic phenotype Int J Cancer 83 1999 255 262
43. Ronnov-Jessen L., and Petersen O.W. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia Lab Invest 68 1993 696 707
44. Tuxhorn J.A., McALhany S.J., and Yang F. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model Cancer Res 62 2002 6021 6025
45. Lieubeau B., Garrigue L., and Barbieux I. The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development Cancer Res 54 1994 6526 6532
46. Desmouliere A., Geinoz A., and Gabbiani F. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts J Cell Biol 122 1993 103 111
47. Arteaga C.L., Coffey R.J. Jr, and Dugger T.C. Growth stimulation of human breast cancer cells with antitransforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta Cell Growth Differ 1 1990 367 374
48. Markowitz S.D., and Roberts A.B. Tumor suppressor activity of the TGF-beta pathway in human cancers Cytokine Growth Factor Rev. 7 1996 93 102
49. Hahn S.A., Schutte M., and Hoque A.T. DPC4, a candidate tumor suppressor gene at human chromosome 18g21.1 Science 271 1996 350 353
50. Markowitz S., Wang J., and Myeroff L. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability Science 268 1995 1336 1338
51. Massagué J., Blain S.W., and Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders Cell 103 2000 295 309
52. Cui W., Fowlis D.J., and Bryson S. TGF-betal inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice Cell 86 1996 531 542
53. Roberts A.B., and Wakefield L.M. The two faces of transforming growth factor beta in carcinogenesis Proc Natl Acad Sci USA 100 2003 8621 8623
54. Gold Ll. The role for transforming growth factorbeta (TGF-beta) in human cancer Crit Rev Oncog 10 1999 303 360
55. Dolberg D.S., Hollingsworth R., and Hertie M. Wounding and its role in RSV-mediated tumor formation Science 230 1985 676 678
56. Sieweke M.H., Thompson N.L., and Sporn M.B. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta Science 248 1990 1656 1660
57. Border W.A., and Noble N.A. Transforming growth factor beta in tissue fibrosis N Engl J Med 331 1994 1286 1292
58. Gressner A.M., Polzar B., and Lahme B. Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor beta Hepatology 23 1996 571 581
59. Tuxhorn J.A., McAlhany S.J., and Dang T.D. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model Cancer Res 62 2002 3298 3307
60. Gorsch S.M., Memoli V.A., and Stukel T.A. Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer Cancer Res 52 1992 6949 6952
61. Friess H., Yamanaka Y., and Buchler M. Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival Gastroenterology 105 1993 1846 1856
62. Wikstrom P., Stattin P., and Franck-Lissbrant I. Transforming growth factor betal is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer Prostate 37 1998 19 29
63. Kim J.H., Shariat S.F., and Kim I.Y. Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder Cancer 92 2001 1475 1483
64. McCawley L.J., and Matrisian L.M. Matrix metalloproteinases: multifunctional contributors to tumor progression Mol Med Today 6 2000 149 156
65. Berking C., Takemoto R., and Schaider H. Transforming growth factor-betal increases survival of human melanoma through stroma remodeling Cancer Res 61 2001 8306 8316
66. De Jong J.S., van Diest P.J., and van der Valk P. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops J Pathol 184 1998 44 52
67. De Jong J.S., van Diest P.J., and van der Valk P. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis J Pathol 184 1998 53 57
68. Pertovaara L., Kaipainen A., and Mustonen T. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells J Biol Chem 269 1994 6271 6274
69. Jussila L., and Alitalo K. Vascular growth factors and Lymphangiogenesis Physiol Rev 82 2002 673 700
70. Yin J.J., Selander K., and Chirgwin J.M. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development J Clin Invest 103 1999 197 206
71. Siegel P.M., Shu W., and Cardiff R.D. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis Proc Natl Acad Sci USA 100 2003 8430 8435
72. Heldin C.H., Eriksson U., and Ostman A. New members of the platelet-derived growth factor family of mitogens Arch Biochem Biophys 398 2002 284 290
73. Waterfield M.D., Scrace G.T., and Whittle N. Plateletderived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus Nature 304 1983 35 39
74. Doolittle R.F., Hunkapiller M.W., and Hood L.E. Simian sarcoma virus oncogene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor Science 221 1983 275 277
75. Pietras K., Sjoblom T., and Rubin K. PDGF receptors as cancer drug targets Cancer Cell 3 2003 439 443
76. Hermanson M., Funa K., and Hartman M. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops Cancer Res 52 1992 3213 3219
77. submitted Sjöblom T., Micke P., and Betsholtz C. Stromal and perivascular expression of the platelet-derived growth factor ss-receptor in normal and malignant tissues 2003
78. Smits A., Funa K., and Vassbotn F.S. Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin Am J Pathol 140 1992 639 648
79. Coltrera M.D., Wang J., and Porter P.L. Expression of plateletderived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma Cancer Res 55 1995 2703 2708
80. Lindmark G., Sundberg C., and Glimelius B. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer Lab Invest 69 1993 682 689
81. Ichiki Y., Smith E., and LeRoy E.C. Different effects of basic fibroblast growth factor and transforming growth factor-beta on the two platelet-derived growth factor receptors' expression in scleroderma and healthy human dermal fibroblasts J Invest Dermatol 104 1995 124 127
82. Psarras S., Kletsas D., and Stathakos D. Restoration of downregulated PDGF receptors byTGF-beta in human embryonic fibroblasts. Enhanced response during cellular in vitro aging FEBS Lett 339 1994 84 88
83. Yamakage A., Kikuchi K., Smith E.A., and Trojanowska M. Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts J Exp Med 175 1992 1227 1234
84. Ishikawa O., LeRoy E.C., and Trojanowska M. Mitogenic effect of transforming growth factor beta 1 on human fibroblasts involves the induction of platelet-derived growth factor alpha receptors J Cell Physiol 145 1990 181 186
85. Forsberg K., Valyi-Nagy I., and Heldin C.H. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB Proc Natl Acad Sci USA 90 1993 393 397
86. Skobe M., and Fusenig N.E. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation Proc Natl Acad Sci USA 95 1998 1050 1055
87. Shao Z.M., Nguyen M., and Barsky S.H. Human breast carcinoma desmoplasia is PDGF initiated Oncogene 19 2000 4337 4345
88. Pietras K., Ostman A., and Sjoquist M. Inhibition of plateletderived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors Cancer Res 61 2001 2929 2934
89. Jain R.K. Delivery of molecular and cellular medicine to solid tumors Adv Drug Deliv Rev 46 2001 149 168
90. Pietras K., Rubin K., and Sjöblom T. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy Cancer Res 62 2002 5476 5484
91. Pietras K., Stumm M., and Hubert M. STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake Clin Cancer Res. 9 2003 3779 3787
92. Brauchte M., Angermeyer K., and Hubner G. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts Oncogene 9 1994 3199 3204
93. Pierce G.F., Tarpley J.E., and Tseng J. Detection of plateletderived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds J Clin Invest 96 1995 1336 1350
94. Halaban R. Growth factors and melanomas Semin Oncol 23 1996 673 681
95. Lindahl P., Johansson B.R., and Leveen P. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice Science 277 1997 242 245
96. Lindblom P., Gerhardt H., and Liebner S. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall Genes Dev 17 2003 1835 1840
97. Furuhashi M., Sjöblom T., and Abramsson A. PDGF production by B16 melanoma cells leads to increased pericyte coverage of vessels and an associated increase in tumor growth rate Cancer Res 64 2004 2725 2733
98. Abramsson A., Lindblom P., and Betsholtz C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors J Clin Invest 112 2003 1142 1151
99. Dunham L.J. Cancer in man at site of prior benign lesion of skin or mucous membrane: a review Cancer Res 32 1972 1359 1374
100. Diehl A.K. Gallstone size and the risk of gallbladder cancer J Am Med Assoc 250 1983 2323 2326
101. Kantor A.F., Hartge P., and Hoover R.N. Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder Cancer Res. 48 1988 3853 3855
102. Paget S. The distribution of secondary growth in cancer of the breast Lancet 1 1889 571 573
103. Barcellos-Hoff M.H., and Ravani S.A. Irradiated mammary gland stroma promotes the expression of Tumorigenic potential by unirradiated epithelial cells Cancer Res 60 2000 1254 1260
104. Moinfar F., Man Y.G., and Arnould L. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis Cancer Res 60 2000 2562 2566
105. DeCosse J.J., Gossens C., and Kuzma J.F. Embryonic inductive tissues that cause histologic differentiation of murine mammary carcinoma in vitro J Natl Cancer Inst 54 1975 913 922
106. DeCosse J.J., Gossens C.L., and Kuzma J.F. Breast cancer: induction of differentiation by embryonic tissue Science 181 1973 1057 1058
107. Cooper M., and Pinkus H. Intrauterine transplantation of rat basal cell carcinoma as a model for reconversion of malignant to benign growth Cancer Res 37 1977 2544 2552
108. Olumi A.F., Grossfeld G.D., and Hayward S.W. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium Cancer Res 59 1999 5002 5011
109. Hayward S.W., Wang Y., and Cao M. Malignant transformation in a nontumorigenic human prostatic epithelial cell line Cancer Res 61 2001 8135 8142
110. Camps J.L., Chang S.M., and Hsu T.C. Fibroblast- mediated acceleration of human epithelial tumor growth in vivo Proc Natl Acad Sci USA 87 1990 75 79
111. Picard O., Rolland Y., and Poupon M.F. Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases Cancer Res 46 1986 3290 3294
112. Gleave M., Hsieh J.T., and Gao C.A. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts Cancer Res 51 1991 3753 3761
113. Parrott J.A., Nilsson E., and Mosher R. Stromal-epithelial interactions in the progression of ovarian cancer: influence and source of tumor stromal cells Mol Cell Endocrinol 175 2001 29 39
114. Elenbaas B., Spirio L., and Koerner F. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells Genes Dev 15 2001 50 65
115. Sternlicht M.D., Lochter A., and Sympson C.J. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis Cell 98 1999 137 146
116. Sympson C.J., Talhouk R.S., and Alexander C.M. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression J Cell Biol 125 1994 681 693
117. Sympson C.J., Talhouk R.S., and Alexander C.M. Erratum J Cell Biol 132 1996 752
118. Thomasset N., Lochter A., and Sympson C.J. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development Am J Pathol 153 1998 457 467
119. Masson R., Lefebvre O., and Noel A. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy J Cell Biol 140 1998 1535 1541
120. Fukumura D., Xavier R., and Sugiura T. Tumor induction of VEGF promoter activity in stromal cells Cell 94 1998 715 725
121. Söderdahl G., Betsholtz C., and Johansson A. Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non small-cell human lung carcinoma lines Int J Cancer 41 1988 636 641
122. Betsholtz C., Bergh J., and Bywater M. Expression of multiple growth factors in a human lung cancer cell line Int J Cancer 39 1987 502 507
123. Kawai T., Hiroi S., and Torikata C. Expression in lung carcinomas of platelet-derived growth factor and its receptors Lab Invest 77 1997 431 436
124. Hasegawa Y., Takanashi S., and Kanehira Y. Transforming growth factor-betal level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma Cancer 91 2001 964 971
125. Demarchi L.M., Reis M.M., and Palomino S.A. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung Mod Pathol 13 2000 511 520
126. Pirinen R., Tammi R., and Tammi M. Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma Int J Cancer 95 2001 12 17
127. Tokunou M., Niki T., and Eguchi K. c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma Am J Pathol 58 2001 1451 1463
128. Anderson I.C., Mari S.E., and Broderick R.J. The angiogenic factor interleukin 8 is induced in non-small cell lung cancer/pulmonary fibroblast cocultures Cancer Res 60 2000 269 272
129. Mari B.P., Anderson I.C., and Mari S.E. Stromelysin-3 is induced in tumor/stroma cocultures and inactivated via a tumorspecific and basic fibroblast growth factor-dependent mechanism J Biol Chem 273 1998 618 626
130. Fromigue O., Louis K., and Dayem M. Gene expression profiling of normal human pulmonary fibroblasts following coculture with non-small-cell lung cancer cells reveals alterations related to matrix degradation, angiogenesis, cell growth and survival Oncogene 22 2003 8487 8497
131. Fridman R., Giaccone G., and Kanemoto T. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines Proc Natl Acad Sci USA 87 1990 6698 6702
132. Sethi T., Rintoul R.C., and Moore S.M. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo Nat Med 5 1999 662 668
133. Chambers A.F., and Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis J Natl Cancer Inst 89 1997 1260 1270
134. Thomas P., Khokha R., and Shepherd F.A. Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer J Pathol 190 2000 150 156
135. Kodate M., Kasai T., and Hashimoto H. Expression of matrix metalloproteinase (gelatinase) in Tl adenocarcinoma of the lung Pathol Int 47 1997 461 469
136. Michael M., Babic B., and Khokha R. Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer J Clin Oncol 17 1999 1802 1808
137. Capdeville R., Buchdunger E., and Zimmermann J. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug Nat Rev Drug Discov 1 2002 493 502
138. Dumont N., and Arteaga C.L. Targeting the TGF beta signaling network in human neoplasia Cancer Cell 3 2003 531 536
139. Shepherd F.A., Giaccone G., and Seymour L. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada - Clinical Trials Group and the European Organization for Research and Treatment of Cancer J Clin Oncol 20 2002 4434 4439
140. Scott A.M., Wiseman G., and Welt S. A phase I doseescalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer Clin Cancer Res 9 2003 1639 1647
141. Micke P., Bjørnsen T., and Scheidl S. A fluid cover medium provides superior morphology and preserves RNA integrity in tissue sections for laser microdissection and pressure catapulting J Pathol 202 2004 130 138